參考文獻(xiàn)/References:
[1] 夏曉龍,陳揚,張偉彬,等.強(qiáng)直性脊柱炎遺傳相關(guān)基因的研究進(jìn)展[J].風(fēng)濕病與關(guān)節(jié)炎,2016,5(2):68-73.
[2] 王秀雯.HLA-B27、ERAP1和CRT之間相互作用在強(qiáng)直性脊柱炎發(fā)病中的研究[D].上海:中國人民解放軍海軍軍醫(yī)大學(xué),2024.
[3] AKKOÇ N,YARKAN H,KENAR G,et al.Ankylosing spondylitis:HLA-B*27-positive versus HLA-B*27-negative di-sease[J].Curr Rheumatol Rep,2017,19(5):26.
[4] 杜冉冉,王師,張火兵,等.HLA-B27與強(qiáng)直性脊柱炎相關(guān)性研究進(jìn)展[J].標(biāo)記免疫分析與臨床,2018,25(4):589-592.
[5] LONDONO J,SANTOS A M,RUEDA J C,et al.Association of ERAP2 polymorphisms in colombian HLA-B27+ or HLA-B15+ patients with SpA and its relationship with clinical presentation:axial or peripheral predominance[J].RMD Open,2020,6(2):e001250.
[6] CORTES A,MAKSYMOWYCH W P,WORDSWORTH B P,et al.Association study of genes related to bone formation and resorption and the extent of radiographic change in ankylosing spondylitis[J].Ann Rheum Dis,2015,74(7):1387-1393.
[7] SAULLE I,VICENTINI C,CLERICI M,et al.An overview on ERAP roles in infectious diseases[J].Cells,2020,9(3):720.
[8] YORK I A,BREHM M A,ZENDZIAN S,et al.Endoplasmic reticulum aminopeptidase 1(ERAP1)trims MHC class I-presented peptides in vivo and plays an important role in immunodominance[J].Proc Natl Acad Sci U S A,2006,103(24):9202-9207.
[9] RASTALL D P,ALDHAMEN Y A,SEREGIN S S,et al.ERAP1 functions override the intrinsic selection of specific antigens as immunodominant peptides,thereby altering the potency of antigen-specific cytolytic and effector memory T-cell responses[J].Int Immunol,2014,26(12):685-695.
[10] ALDHAMEN Y A,SEREGIN S S,RASTALL D P,et al.Endoplasmic reticulum aminopeptidase-1 functions regulate key aspects of the innate immune response[J].PLoS One,2013,8(7):e69539.
[11] BLAKE M K,O'CONNELL P,PEPELYAYEVA Y,et al.ERAP1 is a critical regulator of inflammasome-mediated proinflammatory and ER stress responses[J].BMC Immunol,2022,23(1):9.
[12] 郭愛華,徐滬濟(jì).ERAP1結(jié)構(gòu)與功能研究進(jìn)展[J].分子診斷與治療雜志,2013,5(2):128-133.
[13] TSUJIMOTO M,AOKI K,OHNISHI A,et al.Endoplasmic reticulum aminopeptidase 1 beyond antigenic peptide-processing enzyme in the endoplasmic reticulum[J].Biol Pharm Bull,2020,43(2):207-214.
[14] KOCHAN G,KROJER T,HARVEY D,et al.Crystal structures of the endoplasmic reticulum aminopeptidase-1(ERAP1)reveal the molecular basis for N-terminal peptide trimming[J].Proc Natl Acad Sci U S A,2011,108(19):7745-7750.
[15] 王冠明,游玉權(quán),謝永華,等.ERAP1與強(qiáng)直性脊柱炎關(guān)系研究進(jìn)展[J].生命科學(xué),2015,27(7):898-902.
[16] SAAD M A,ABDUL-SATTAR A B,ABDELAL I T,et al.Association of endoplasmic reticulum aminopeptidase 1 gene polymorphism with susceptibility and severity of axial spondyloarthritis in egyptian population:a single-center case-control study[J].Ann Afr Med,2024,23(3):443-451.
[17] Wellcome Trust Case Control Consortium,Australo-Anglo-American Spondylitis Consortium(TASC),BURTON P R,et al.Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants[J].Nat Genet,2007,39(11):1329-1337.
[18] 謝志雄,吳麗萍,房光萃,等.內(nèi)質(zhì)網(wǎng)氨基肽酶-1基因(ERAP1)多態(tài)性與閩南地區(qū)漢族人群強(qiáng)直性脊柱炎關(guān)聯(lián)性研究[J].現(xiàn)代免疫學(xué),2016,36(3):224-229.
[19] HASSAN S H,AUDA I G,ALI E N,et al.Role of endoplasmic reticulum aminopeptidase-1 gene polymorphism(rs13167972)in occurrence susceptibility of ankylosing spondylitis in a sample of Iraqi male patients[J].Mol Biol Rep,2024,51(1):462.
[20] KADI A,IZAC B,SAID-NAHAL R,et al.Investigating the genetic association between ERAP1 and spondyloarthritis[J].Ann Rheum Dis,2013,72(4):608-613.
[21] 蘇文成.ERAP1、ERAP2、RUNX3基因多態(tài)性與強(qiáng)直性脊柱炎和急性前葡萄膜炎遺傳易感性的研究[D].重慶:重慶醫(yī)科大學(xué),2018.
[22] 劉倩.強(qiáng)直性脊柱炎炎性標(biāo)志物及ERAP-1 rs30187單核苷酸多態(tài)性研究[D].北京:北京協(xié)和醫(yī)學(xué)院,2022.
[23] 曲哲,錢邦平,邱勇,等.ERAP1基因單核苷酸多態(tài)性與中國漢族人群強(qiáng)直性脊柱炎的易感性關(guān)聯(lián)分析[J].中國脊柱脊髓雜志,2015,25(9):832-836.
[24] CAI G,XIN L,WANG L,et al.Associations between ERAP1 polymorphisms and ankylosing spondylitis susceptibility:an updated meta-analysis[J].Mod Rheumatol,2015,25(3):453-461.
[25] CHERCIU M,POPA L O,BOJINCA M,et al.Functional variants of ERAP1 gene are associated with HLA-B27 positive spondyloarthritis[J].Tissue Antigens,2013,82(3):192-196.
[26] HANSON A,BROWN M A.Genetics and the causes of ankylosing spondylitis[J].Rheum Dis Clin North Am,2017,43(3):401-414.
[27] GARCÍA-MEDEL N,SANZ-BRAVO A,ALVAREZ-NAVARRO C,et al.Peptide handling by HLA-B27 subtypes influences their biological behavior,association with ankylosing spondylitis and susceptibility to endoplasmic reticulum aminopeptidase 1(ERAP1)[J].Mol Cell Proteomics,2014,13(12):3367-3380.
[28] JIANG P,VEENSTRA R N,SEITZ A,et al.Interaction between ERAP alleles and HLA class I types support a role of antigen presentation in hodgkin lymphoma development[J].Cancers(Basel),2021,13(3):414.
[29] SAAD M A,ABDUL-SATTAR A B,ABDELAL I T,et al.Shedding light on the role of ERAP1 in axial spondyloarthritis[J].Cureus,2023,15(11):e48806.
[30] ZHU W,HE X,CHENG K,et al.Ankylosing spondylitis:etiology,pathogenesis,and treatments[J].Bone Res,2019,7:22.
[31] DELAY M L,TURNER M J,KLENK E I,et al.HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats[J].Arthritis Rheum,2009,60(9):2633-2643.
[32] 劉彧.強(qiáng)直性脊柱炎免疫遺傳學(xué)發(fā)生機(jī)制的研究進(jìn)展[J].中國臨床醫(yī)學(xué),2019,26(1):117-121.
[33] GARCÍA-MEDEL N,SANZ-BRAVO A,VAN NGUYEN D,et al.Functional interaction of the ankylosing spondylitis-associated endoplasmic reticulum aminopeptidase 1 polymorphism and HLA-B27 in vivo[J].Mol Cell Proteomics,2012,11(11):1416-1429.
[34] CHEN L,RIDLEY A,HAMMITZSCH A,et al.Silencing or inhibition of endoplasmic reticulum aminopeptidase 1(ERAP1)suppresses free heavy chain expression and Th17 responses in ankylosing spondylitis[J].Ann Rheum Dis,2016,75(5):916-923.
[35] HAROON N,TSUI F W,UCHANSKA-ZIEGLER B,et al.Endoplasmic reticulum aminopeptidase 1(ERAP1)exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis[J].Ann Rheum Dis,2012,71(4):589-595.
[36] MA Y,FAN D,XU S,et al.Ankylosing spondylitis patients display aberrant ERAP1 gene DNA methylation and expression[J].Immunol Invest,2022,51(6):1548-1560.
[37] GUERINI F R,CAGLIANI R,FORNI D,et al.A functional variant in ERAP1 predisposes to multiple sclerosis[J].PLoS One,2012,7(1):e29931.
[38] KOCHAN G,KROJER T,HARVEY D,et al.Crystal structures of the endoplasmic reticulum aminopeptidase-1(ERAP1)reveal the molecular basis for N-terminal peptide trimming[J].Proc Natl Acad Sci U S A,2011,108(19):7745-7750.
[39] CHOI C B,KIM T H,JUN J B,et al.ARTS1 polymorphisms are associated with ankylosing spondylitis in Koreans[J].Ann Rheum Dis,2010,69(3):582-584.
[40] REEVES E,COLEBATCH-BOURN A,ELLIOTT T,et al.Functionally distinct ERAP1 allotype combinations distinguish individuals with ankylosing spondylitis[J].Proc Natl Acad Sci U S A,2014,111(49):17594-17599.
[41] 爭鳴.T細(xì)胞在強(qiáng)直性脊柱炎發(fā)生機(jī)制中的作用[D].西安:中國人民解放軍空軍軍醫(yī)大學(xué),2020.
[42] HEMMATZADEH M,BABAIE F,EZZATIFAR F,et al.Susceptibility to ERAP1 gene single nucleotide polymorphism modulates the inflammatory cytokine setting in ankylosing spondylitis[J].Int J Rheum Dis,2019,22(4):715-724.
[43] MOHAMMADI H,BABAIE F,HEMMATZADEH M,et al.Evaluation of ERAP1 gene single nucleotide polymorphism in impressing the inflammatory cytokine profile of ankylosing spondylitis patients[J].Iran J Allergy Asthma Immunol,2018,17(5):464-474.
相似文獻(xiàn)/References:
[1]閻曉霞,任之強(qiáng),仝允輝,等.布魯氏菌性脊柱炎3例[J].中醫(yī)正骨,2015,27(06):64.
[2]趙偉光,劉振武,劉利,等.強(qiáng)直性脊柱炎合并右側(cè)股骨頭和股骨頸骨溶解癥1例[J].中醫(yī)正骨,2015,27(01):75.
[3]黃建武,黃建華,黃影.腫瘤壞死因子-α在強(qiáng)直性脊柱炎活動期患者中的表達(dá)[J].中醫(yī)正骨,2013,25(11):22.
[4]張董喆,孔超,張建福.針刺夾脊穴結(jié)合督灸治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2014,26(07):58.
[5]吳建國.強(qiáng)直性脊柱炎并發(fā)脊柱骨折的影像學(xué)表現(xiàn)[J].中醫(yī)正骨,2013,25(06):31.
[6]謝國華,薛峰,楊建平,等.強(qiáng)直性脊柱炎脊柱應(yīng)力性骨折的診斷[J].中醫(yī)正骨,2012,24(12):72.
[7]張萬義,張永紅,王笑青.雙醋瑞因膠囊聯(lián)合柳氮磺胺吡啶腸溶片與右旋布洛芬膠囊治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2012,24(06):26.
ZHANG Wan-yi*,ZHANG Yong-hong,WANG Xiao-qing.*.Study on the curative effects of diacerein capsules combined with sulfasalazine enteric-coated tablets and dextral ibuprofen capsules in the treatment of ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(01):26.
[8]黃建華,黃建武,陳金春,等.早期強(qiáng)直性脊柱炎血管內(nèi)皮生長因子、C反應(yīng)蛋白
表達(dá)水平的臨床研究[J].中醫(yī)正骨,2012,24(02):9.
HUANG Jian-hua*,HUANG Jian-wu,CHEN Jin-chun,et al.Clinical research on the expression of VEGF、CRP in early ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(01):9.
[9]王笑青,張永紅,王玉麗,等.常規(guī)藥物口服配合中藥離子導(dǎo)入治療強(qiáng)直性脊柱炎肌腱附著點炎[J].中醫(yī)正骨,2011,23(10):18.
WANG Xiao-qing*,ZHANG Yong-hong,WANG Yu-li,et al.A study on the curative effects of oral conventional drugs combined with traditional Chinese medicine iontophoresis on ankylosing spondylitis tendon enthesitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(01):18.
[10]劉紅軍.單節(jié)段楔形截骨結(jié)合椎弓根A-F系統(tǒng)內(nèi)固定
治療強(qiáng)直性脊柱炎脊柱后凸畸形[J].中醫(yī)正骨,2011,23(09):65.
[11]戴霞華,李寅潔.指導(dǎo)性功能鍛煉在兒童強(qiáng)直性脊柱炎護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2015,27(10):78.
[12]張夢雨,鮑鐵周,田江波.督脈隔姜灸聯(lián)合柳氮磺吡啶腸溶片口服及
功能鍛煉治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2015,27(09):44.
[13]赫軍,諸葛天諭,李冬冬,等.中藥內(nèi)服聯(lián)合針刺與埋針法治療幼年強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(01):41.
[14]赫軍,諸葛天諭,李冬冬,等.四聯(lián)療法治療強(qiáng)直性脊柱炎[J].中醫(yī)正骨,2016,28(06):50.
[15]張遂連,袁星星.自我管理在強(qiáng)直性脊柱炎患者門診護(hù)理中的應(yīng)用[J].中醫(yī)正骨,2017,29(03):79.
[16]李現(xiàn)林,薛華珍,陳星,等.口服通痹舒筋丸治療強(qiáng)直性脊柱炎寒濕痹阻證[J].中醫(yī)正骨,2017,29(05):31.
[17]龔家川.影響強(qiáng)直性脊柱炎患者髖關(guān)節(jié)受累的危險因素分析[J].中醫(yī)正骨,2017,29(06):25.
GONG Jiachuan.Analysis of risk factors for affection of hip joint in patients with ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):25.
[18]黃小龍,全仁夫,胡華輝,等.HLA-B2704基因型強(qiáng)直性脊柱炎患者來源的人誘導(dǎo)多能干細(xì)胞體系的建立[J].中醫(yī)正骨,2017,29(12):11.
HUANG Xiaolong,QUAN Renfu,HU Huahui,et al.Establishment of human-induced pluripotent stem cells system originated from patients with HLA-B2704 genotypic ankylosing spondylitis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(01):11.
[19]李洛宜,張依山,王笑青,等.系列化視頻在強(qiáng)直性脊柱炎健康教育中的應(yīng)用[J].中醫(yī)正骨,2018,30(03):78.
[20]任偉凡,胡勁濤,全仁夫,等.強(qiáng)直性脊柱炎易感基因的相關(guān)研究進(jìn)展[J].中醫(yī)正骨,2019,31(04):48.